Suthogen

Sulfadiazine One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.

[(Science: drug) A sulpha drug used in combination with pyrimethamine for treating toxoplasmosis. possible side effects include bone marrow suppression.

Molecular Formula: C₁₀H₉N₄NaO₂S

InChI: InChI=1/C10H9N4O2S.Na/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10;/h1-7H,11H2;/q-1;+1

InChIKey: InChIKey=JLDCNMJPBBKAHH-UHFFFAOYAJ
SMILES: C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Na+]

Names:
    Sodium sulfadiazine
    Sodium sulfapyrimidine
    sodium (4-aminophenyl)sulfonyl-pyrimidin-2-yl-azanide
    Solfadiazina sodica [DCIT]
    Soluble sulfadiazine
    Soludiazine
    Sulfadiazine sodium [USAN:INN]
    SULFADIAZINE SODIUM
    Sulfadiazin-natrium
    Sulphadiazine
    Suthogen

Registries:
    PubChem CID 11031
    PubChem ID 154335